High-Throughput Biochemical Kinase Selectivity Assays: Panel Development and Screening Applications
- 21 November 2008
- journal article
- Published by Elsevier BV in Journal of Biomolecular Screening
- Vol. 14 (1), 31-42
- https://doi.org/10.1177/1087057108326663
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Review: Side Effects of Approved Molecular Targeted Therapies in Solid CancersThe Oncologist, 2007
- Targeting Tyrosine Kinases in Cancer: The Second WaveScience, 2006
- The second wave in kinase cancer drugsNature Biotechnology, 2006
- Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)The Lancet, 2005
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Kinase Inhibition with BAY 43–9006 in Renal Cell CarcinomaClinical Cancer Research, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivoBlood, 2003
- The Protein Kinase Complement of the Human GenomeScience, 2002